4//SEC Filing
Jones Marie L. 4
Accession 0001140361-24-041414
CIK 0001397702other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 8:35 PM ET
Size
10.6 KB
Accession
0001140361-24-041414
Insider Transaction Report
Form 4
Jones Marie L.
CAO and VP, Finance
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2024-09-17$21.39/sh−71,661$1,532,829→ 0 totalExercise: $6.11Exp: 2028-03-22→ Common Stock (71,661 underlying) - Disposition to Issuer
Common Stock
2024-09-17−79,266→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2024-09-17$21.39/sh−16,518$353,320→ 0 totalExercise: $6.11Exp: 2028-09-23→ Common Stock (16,518 underlying)
Footnotes (6)
- [F1]Of the reported shares, 49,414 are represented by restricted stock units, or RSUs, each of which represents a contingent right to receive one share of Issuer common stock.
- [F2]Includes 2,000 shares and 372 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan on May 20, 2024 and September 13, 2024, respectively.
- [F3]Pursuant to the Agreement and Plan of Merger dated June 17, 2024, between the Issuer, Boston Scientific Corporation and Seminole Merger Sub, Inc, (the "Merger Agreement"), each share of Issuer common stock was canceled and converted into the right to receive $27.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding taxes.
- [F4]Pursuant to the Merger Agreement, each RSU was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares underlying the RSUs, less applicable taxes and authorized deductions.
- [F5]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $1,532,828.79 which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
- [F6]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $353,320.02, which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
Documents
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
Related Parties
1- filerCIK 0001968991
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 8:35 PM ET
- Size
- 10.6 KB